AU Patent

AU2014345507B2 — Crystalline beta-lactamase inhibitor

Assigned to Orchid Pharma Ltd · Expires 2018-11-22 · 7y expired

What this patent protects

A crystalline compound of formula (I): Formula (I). The compound of formula (I) is a β-lactamase inhibitor and may be administered in combination with an antibacterial agent for prevention or treatment of bacterial infection.

USPTO Abstract

A crystalline compound of formula (I): Formula (I). The compound of formula (I) is a β-lactamase inhibitor and may be administered in combination with an antibacterial agent for prevention or treatment of bacterial infection.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014345507B2
Jurisdiction
AU
Classification
—
Expires
2018-11-22
Drug substance claim
No
Drug product claim
No
Assignee
Orchid Pharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.